These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16440835)

  • 1. On the treatment effect in clinical trials with dropout.
    Shao J; Zhong B
    J Biopharm Stat; 2006; 16(1):25-33. PubMed ID: 16440835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.
    Siddiqui O; Ali MW
    J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline observation carry forward: reasoning, properties, and practical issues.
    Shao J; Jordan DC; Pritchett YL
    J Biopharm Stat; 2009 Jul; 19(4):672-84. PubMed ID: 20183433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative way to classify missing data mechanism in clinical trials--a dialogue on missing data.
    Wei L
    J Biopharm Stat; 2011 Mar; 21(2):355-61. PubMed ID: 21391007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling placebo response in depression trials using a longitudinal model with informative dropout.
    Gomeni R; Lavergne A; Merlo-Pich E
    Eur J Pharm Sci; 2009 Jan; 36(1):4-10. PubMed ID: 19041717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of longitudinal binary data with missing data due to dropouts.
    Ali MW; Talukder E
    J Biopharm Stat; 2005; 15(6):993-1007. PubMed ID: 16279357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple imputation compared with some informative dropout procedures in the estimation and comparison of rates of change in longitudinal clinical trials with dropouts.
    Ali MW; Siddiqui O
    J Biopharm Stat; 2000 May; 10(2):165-81. PubMed ID: 10803723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Handling missing data in vaccine clinical trials for immunogenicity and safety evaluation.
    Li X; Wang WW; Liu GF; Chan IS
    J Biopharm Stat; 2011 Mar; 21(2):294-310. PubMed ID: 21391003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian analysis of hierarchical pattern-mixture models for clinical trials data with attrition and comparisons to commonly used ad-hoc and model-based approaches.
    Demirtas H
    J Biopharm Stat; 2005; 15(3):383-402. PubMed ID: 15920887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accounting for dropout bias using mixed-effects models.
    Mallinckrodt CH; Clark WS; David SR
    J Biopharm Stat; 2001; 11(1-2):9-21. PubMed ID: 11459446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation.
    Cook RJ; Zeng L; Yi GY
    Biometrics; 2004 Sep; 60(3):820-8. PubMed ID: 15339307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intent-to-treat analysis for longitudinal studies with drop-outs.
    Little R; Yau L
    Biometrics; 1996 Dec; 52(4):1324-33. PubMed ID: 8962456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dropouts in longitudinal studies: definitions and models.
    Lindsey JK
    J Biopharm Stat; 2000 Nov; 10(4):503-25. PubMed ID: 11104390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for the presence of multiple sources of informative dropout in longitudinal data.
    Crawford SB; Hanfelt JJ
    Stat Med; 2008 Sep; 27(21):4175-89. PubMed ID: 18613222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dropout rates for intent-to-treat and per protocol analyses.
    Stewart WC; Jackson AL; Jenkins JN
    Am J Ophthalmol; 2004 Apr; 137(4):639-45. PubMed ID: 15059702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Random effects and latent processes approaches for analyzing binary longitudinal data with missingness: a comparison of approaches using opiate clinical trial data.
    Albert PS; Follmann DA
    Stat Methods Med Res; 2007 Oct; 16(5):417-39. PubMed ID: 17656452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.